Partner Harvey Kesner Represents MusclePharm Corporation in $6M Financing
Press Release – New York, NY – December 10, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented MusclePharm Corporation (OTCQX: MSLP) (the “Company”), a scientifically driven, performance-lifestyle sports nutrition company, in connection with its sale of a convertible secured promissory note in the principal amount of $6,000,000 to Ryan Drexler, the Executive Chairman of the Company. The Sichenzia Ross Friedman Ference LLP team was led by partner Harvey Kesner, counsel Ed Schauder and associates Avital Even-Shoshan and Lijia Sanchez.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Attorney - July 17, 2017
- Partner Harvey Kesner Rings Nasdaq Opening Bell with Laidlaw & Company (UK) Ltd. and Therapix Biosciences Ltd. - June 28, 2017
- Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a$7.4 Million Public Offering of Medical Transcript Billing, Corp. - June 28, 2017